CN Patent

CN109789133A — 多奈哌齐透皮递送系统

Assigned to Corium LLC · Expires 2019-05-21 · 7y expired

What this patent protects

描述了用于全身递送多奈哌齐的透皮递送系统，其中所述系统包含药物储库层，所述药物储库层包含丙烯酸酯共聚物、甘油和通过多奈哌齐盐酸盐与碱性盐的反应原位产生的多奈哌齐碱。该系统用于治疗阿尔茨海默病，并实现与口服给予治疗剂生物等效的治疗剂的透皮递送。

USPTO Abstract

描述了用于全身递送多奈哌齐的透皮递送系统，其中所述系统包含药物储库层，所述药物储库层包含丙烯酸酯共聚物、甘油和通过多奈哌齐盐酸盐与碱性盐的反应原位产生的多奈哌齐碱。该系统用于治疗阿尔茨海默病，并实现与口服给予治疗剂生物等效的治疗剂的透皮递送。

Drugs covered by this patent

donepezil-hydrochloride (DONEPEZIL HYDROCHLORIDE)

Patent Metadata

Patent number: CN109789133A
Jurisdiction: CN
Classification: —
Expires: 2019-05-21
Drug substance claim: No
Drug product claim: No
Assignee: Corium LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.